UNSPSC 85501430: Supplement right internal carotid artery with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right internal carotid artery with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03UK4KZ

UNSPSC 85501430 Supplement right internal carotid artery with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows minimal relevance to actual state and local procurement activity. The code describes a highly specific surgical procedure—vascular supplementation of the internal carotid artery using nonautologous tissue in a percutaneous endoscopic setting—yet the six recent opportunities posted under this code reflect administrative and occupational medical services, pharmacy benefit management, health professional staffing, and pediatric detention healthcare, none of which align with the procedural scope the code nominally represents. State and local procurement offices appear to have applied this code to general healthcare administration and staffing solicitations rather than to the surgical intervention the code names.

The recent opportunities span Arizona, California, Washington, Texas, and Florida, issued by diverse jurisdictions including city retirement offices, municipal human resources departments, state transportation agencies, county health systems, and juvenile detention authorities. No single issuing body appears more than once in the recent record. Given the fundamental disconnect between the code's procedural definition and the administrative and staffing services actually being solicited under it, this code lacks a coherent market signal and should be treated as a filing error rather than an active procurement category for surgical device, implant, or procedural service vendors. Firms pursuing medical device, tissue substitute, or vascular procedure work should rely on alternative code paths rather than monitoring this category.